Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DR26F6CA9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,242
Award facts
- Contract value 100% obligated
- $14,242.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,242.26 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen per milliliter formulation. This is a firm fixed-price delivery order issued on November 13, 2025, with an ultimate completion date of November 14, 2025, and represents a non-competitive, non-set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This delivery order for Cosentyx, an immunosuppressant used in treating inflammatory conditions, exemplifies the type of specialty pharmaceutical products supplied through this contract vehicle.
Quick answers
Who was awarded contract SPE2DR26F6CA9?
SPE2DR26F6CA9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F6CA9 worth?
The government has obligated $14,242 on SPE2DR26F6CA9.
Is contract SPE2DR26F6CA9 an order under another contract?
Yes. SPE2DR26F6CA9 is a delivery order under SPE2DR25D1052, an indefinite delivery contract.
Was contract SPE2DR26F6CA9 competed?
The extent of competition for SPE2DR26F6CA9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award